Bit-225 Intermediate
have 0 Relevant products
Bit 225 Is An Experimental Candidate Drug Being Developed By Biotron Limited For The Treatment Of Hiv And Hepatitis C Infection. By Blocking The Activity Of Vpu Ion Channels, It Disrupts The Assembly Of Hiv In Host Monocytes; Its Mode Of Action Is The Fir
